コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 justify policy change towards imminent death donation.
2 atients having baseline contraindication for donation.
3 PrEP use within the same time frame as blood donation.
4 67%) and mean age was 38.9 +/- 11.2 years at donation.
5 by amplifying the benefit derived from their donation.
6 eased donors and the safety of living kidney donation.
7 ance that all patients have timely access to donation.
8 the location, time, and quantity of analyte donation.
9 hospitals were admitted to the ICU for organ donation.
10 is dead but are also asked to consider organ donation.
11 inform and prepare donors for outcomes after donation.
12 ial media can be influential in living organ donation.
13 tation should be considered for living-liver donation.
14 highlighting the success and impact of organ donation.
15 nd inexpensive adjunct therapy in multiorgan donation.
16 ere more fearful of being alive during organ donation.
17 7% of the participants were aware of corneal donation.
18 e Ru(V)-oxo moiety via a strong pai-electron donation.
19 donors and their healthcare providers about donation.
20 rrest (OHCA) patients were screened for uDCD donation.
21 or normothermia (36.5-37.5 degrees C) before donation.
22 in this rodent model of marginal DCD cardiac donation.
23 ained normotensive during the 6 hours before donation.
24 ir payment for participation as a charitable donation.
25 ple seek to benefit from their very generous donation.
26 are appropriate candidates for partial liver donation.
27 represent a formal contraindication for live donation.
28 significant stabilization of 5 via Ru -> Zn donation.
29 d as a potential consequence of nonheart DCD donation.
30 e data to identify patients capable of large donations.
31 rgan donor or in products derived from these donations.
32 athy than men in messages accompanying their donations.
33 dependent on the rate of assumed infectious donations.
34 ors associated with requesting living kidney donations.
35 sults indicating that 11% of these anonymous donations (2.3% of all donations) are not attributable t
37 y-nine (98%) patients transitioned to actual donation after BD, with 1.2 organs transplanted per dono
39 R), we compared outcomes after DCD in FHF to donation after brain death (DBD) in FHF and DCD in non-F
41 (2010-2018), outcomes of 30 DCD SLK and 131 donation after brain death (DBD) SLK from Mayo Clinic Ar
42 Circulatory Death (DCD) is an alternative to Donation after Brain death (DBD), and is a growing strat
44 vs 39.5 years, P < 0.0001), more frequently donation after cardiac death (DCD) (18% vs 7%, P < 0.001
46 ly function immediately, whereas organs from donation after cardiac death (DCD) or acute kidney injur
47 how hepatectomy time (HT), in the context of donation after cardiac death (DCD) procurement, impacts
49 nors (HBD), and from donors with 30 minutes (donation after cardiac death [DCD]30'), 70 minutes (DCD7
50 plant, older recipient age, older donor age, donation after cardiac death, and longer cold ischemia.
51 ble and nonviable organs, local cost levels, donation after cardiac death, year, and Standardized Don
52 kg/m, P = 0.01), and transplantation with a donation after circulatory death (aIRR 5.38, P = 0.001)
53 Liver transplantation (LT) from controlled donation after circulatory death (cDCD) was initiated in
54 Limited data exist regarding the impact of donation after circulatory death (DCD) allografts on out
57 or livers that are both steatotic and from a donation after circulatory death (DCD) donor, there is a
58 Transplantation of hearts retrieved from donation after circulatory death (DCD) donors is an evol
59 cern in liver transplantation of grafts from donation after circulatory death (DCD) donors remains th
60 med with livers from heart-beating donors or donation after circulatory death (DCD) donors subjected
61 utilization of liver and kidney grafts from donation after circulatory death (DCD) donors who died f
62 controversial whether renal allografts from donation after circulatory death (DCD) have a higher ris
65 lly defined delayed graft function (fDGF) in donation after circulatory death (DCD) kidney transplant
68 uid was collected from 48 kidney grafts from donation after circulatory death (DCD) or donation after
69 idney transplant (SLKT) are opting to accept donation after circulatory death (DCD) organs as a means
70 to undergo beating-heart donation (n = 9) or donation after circulatory death (n = 8) induced by hypo
75 nt and conditioning of abdominal organs from donation after circulatory death donors with reported im
76 aNRP with standard procurement technique in donation after circulatory death donors would be needed
77 r preservation strategies for the storage of donation after circulatory death grafts are essential to
78 l normothermic regional perfusion (aNRP) for donation after circulatory death is an emerging organ pr
79 s the incidence of delayed graft function in donation after circulatory death kidney transplantation.
80 E treatment protected recipients of extended donation after circulatory death kidneys from immune act
82 ments, the immune response was assessed in a donation after circulatory death model of kidney transpl
83 nt a novel, superior preservation option for donation after circulatory death renal grafts compared w
87 family members who were approached for organ donation after the death of their relative in the ICU (b
88 family members who were approached for organ donation after the death of their relative in the ICU (b
90 a statistically significant increase in lung donations after implementing rotational positioning of d
95 nce of social grooming and regurgitated food donations among previously unfamiliar captive vampire ba
96 level of awareness (32.7%) of transplant and donation amongst the study population but a good level o
97 e both significantly affected by the average donation amounts visible at the time of their decisions,
100 ND-LLDs demonstrated acceptable HR-QOL after donation and are appropriate candidates for partial live
101 2015 (n = 1012) were surveyed 6 months after donation and asked about occupation, time to return to w
102 Beliefs about the negative consequences of donation and concerns over the medical care given to pot
105 There was a substantial reduction in organ donation and liver transplantation activity across the 3
106 as led to a significant contraction in organ donation and liver transplantation in all 3 countries.
108 ubstantially contributes to increasing organ donation and offers more patients the chance of donating
109 nderstanding of the consent system for organ donation and some important nuances about the role of fa
110 atients develop adequate antibody titers for donation and the relationship between avidity and neutra
112 is anecdotal evidence of reduction in organ donation and transplantation activity across the world.
115 institutions need to plan for reductions in donations and loss of crucial staff because of sickness
116 cipants met inclusion criteria and completed donations and psychological evaluations of perceived str
117 iews of brain death continue to hamper organ donation, and are seemingly resistant to both time and l
119 a graft's "intrinsic quality" at the time of donation, and further support the use of intraoperative
120 discuss their fears and concerns about organ donation, and given an immediate opportunity to register
122 to specialized cardiac arrest centers, organ donation, and performance measurement across the continu
124 y genomic research is necessary and how data donation, and subsequent sharing, is integral to this.
125 and NDDs from the Alliance for Paired Kidney Donation, and the actual DDs from the Scientific Registr
126 04), perceived kidney disease risk following donation (aOR, 1.68; 95% CI, 1.03, 2.73, P = .03), inter
127 onors in the United States who were obese at donation are at increased risk of end-stage renal diseas
128 ons combined with the An-L delta or phi back-donations are crucial in explaining this non-classical t
129 1% of these anonymous donations (2.3% of all donations) are not attributable to any egoistic goal.
131 ighlight the importance of postmortem tissue donations as an invaluable resource to accelerate resear
132 ld continue to remain a contraindication for donation, as has been the initial response of donation a
136 nitiate chains of living donor kidney paired donation, but the potential gains of this practice need
140 od, inter-donation intervals for whole blood donation can be safely reduced to meet blood shortages.
144 monstrate that the direct L-An sigma and pai donations combined with the An-L delta or phi back-donat
145 isk of end-stage kidney disease (ESKD) after donation compared with healthy nondonors for multiple po
146 al interaction, whereas the Fe -> P pai-back-donation corresponds to ~15% of the orbital interaction.
147 osophical dilemma, a medical dilemma, a real donation decision between a more vs. less effective char
148 lia's "opt-in" system, people register their donation decision on the Australian Organ Donor Register
149 e (:BR) complexes via metal d(pai) ->BR back-donation, despite the electron deficiency of boron.
150 spite of caregivers' efforts to focus organ donation discussions and decision on the patient, family
152 sques randomized to an early arm where organ donation education preceded a control educational worksh
154 individuals in their decisions around tissue donation following MAiD, while highlighting how healthca
155 In this Viewpoint, we argue that tissue donation following medical assistance in death (MAiD) wi
156 cs and seroreactivity after testing of blood donations for severe acute respiratory syndrome coronavi
157 and maximize the favorable hyperconjugative donation from each nitrogen atom into neighboring electr
159 ion after circulatory death (uDCD) refers to donation from persons who die following an unexpected an
160 ce 2010, 60 postmortem pediatric brain tumor donations from 26 institutions were coordinated and coll
162 analytical equilibrium calculations for the donation game and evolutionary simulations for several o
163 Prosocial behaviours are encountered in the donation game, the prisoner's dilemma, relaxed social di
165 elf-reported symptoms potentially related to donation, haemoglobin and ferritin concentrations, and d
167 quantify the association between early post-donation hypertension and recipient graft failure using
168 rogram of Intensive Care to facilitate Organ Donation (ICOD) in 2 Spanish centers based on a common p
170 religious (Islamic Knowledge of Living Organ Donation, IK-LOD) living kidney donation knowledge.
173 ncontrolled DCD donors (uDCDs) have expanded donation in Europe since the 1980s, but are seldom used
175 espite adjustment for donor characteristics, donation in the more recent era remained a significant p
176 e was early evidence of recovery of deceased donation in the United States and United Kingdom and res
177 The first sustained increase in live kidney donation in the United States in 15 years was observed f
181 ents with contraindications to both deceased donation (including infection, malignancy, cardiopulmona
183 gens has been effective in identifying blood donations infected with the classic transfusion-transmit
184 ing the significance of these delta/phi back-donation interactions, and their importance for complexe
185 emoglobin (difference per week shorter inter-donation interval -0.84 g/L [95% CI -0.99 to -0.70] in m
186 percentage difference per week shorter inter-donation interval -6.5% [95% CI -7.6 to -5.5] in men and
187 emoglobin (odds ratio per week shorter inter-donation interval 1.19 [95% CI 1.15-1.22] in men and 1.1
188 the extension study, each week shorter inter-donation interval increased blood collection by a mean o
189 cipation on their originally allocated inter-donation intervals (men: 12, 10, and 8 weeks; women: 16,
190 ial showed that, over a 2-year period, inter-donation intervals for whole blood donation can be safel
191 ger-term risks and benefits of varying inter-donation intervals, and to compare routine versus more i
192 Every ICU admission to incorporate organ donation into end-of-life care was systematically evalua
195 Evidence about outcomes after living kidney donation is needed both to inform donor acceptance crite
196 ison with a healthy cohort suggest that live donation is not associated with excess mortality, end-st
199 d growth of large, multicenter kidney-paired donation (KPD) clearinghouses have broadened the transpl
201 ar experience of Mayo Clinic's kidney paired donation (KPD).We aimed to determine the benefits for th
204 g employee education, office decoration with donation materials, and customer experience improvements
207 ntext, the criteria that govern living donor donations must live up to very demanding standards as we
208 pigs were assigned to undergo beating-heart donation (n = 9) or donation after circulatory death (n
210 life in expectation by triggering a targeted donation of 350 euros or received an amount of 100 euros
213 region; then, the P-O bond formation via the donation of electron density of the nonbonding region of
214 he C-C bond formation, which takes place via donation of electron density of the ylide carbon to the
217 electron density of metal NPs through sigma-donation of NHCs substantially improve the selectivity f
219 fluence and direct chemical reaction through donation of strong hydrogen bonds while being weak accep
221 tion, moment to approach families to discuss donation opportunities, criteria for the determination o
222 t associated with the rate of deceased organ donation or median waiting time for transplant in indivi
223 s of the deceased, which can mean preventing donation, or permitting donation when the deceased refus
224 SRD is rare, an earlier and more common post-donation outcome could serve as a surrogate to individua
225 ), increasing awareness about deceased organ donation (P < 0.01), and advertising for transplant cent
226 donor nephrectomy has increased live kidney donation, paving the way for further innovation to expan
227 , and reinforce that the WHO target of 10-20 donations per 1000 population is an underestimate for ma
228 and treatments that also remove IgG (plasma donation, plasma exchange, immunoadsorption); (c) diseas
231 itiating kidneys (DD-CIK) in a kidney paired donation pool (KPDP), and estimate potential increases i
232 donation (IDD) is described as living organ donation prior to a planned withdrawal of life-sustainin
236 The National Kidney Registry (NKR) Advanced Donation Program enables living donors the opportunity t
238 s and 16 pairs enrolled in the kidney paired donation program, it was possible to transplant 8 of 16
239 We argue that the expansion of medicine donation programmes and the development of new medicines
242 OPOs changed their pass/fail status for the donation rate and 5 for the proposed organ transplant ra
243 7, 31 (53%) OPOs failed to meet the proposed donation rate standard, 36 (62%) failed to meet the prop
246 n in the United States would improve overall donation rates and provide a pathway to utilize these id
250 Although Gulf State DSAs have lower expected donation rates, these differences appear to be driven by
253 from certain causes that could lead to organ donation, rather than the current unverifiable eligible
255 ovel program thus yielded significant kidney donation-related knowledge gains among Muslim Americans
258 with obesity (body mass index, >=30 kg/m) at donation reported to the Scientific Registry of Transpla
260 r to be related to network size or to living donation requests, but rather to the network members the
261 ng sex and gender in allotransplantation and donation research during study design and analysis.
265 to the lung allocation policy eliminated the donation service area (DSA) as the first geographic tier
269 ntation across centers nationally and within donation service areas (DSAs), we conducted a registry s
271 rdam Renal Replacement Knowledge Test living donation subscale, R3KT) and religious (Islamic Knowledg
273 ever, graft failure was associated with post-donation systolic blood pressure (per 10 mmHg, aHR 1.05,
274 e also examined the association between post-donation systolic blood pressure and graft failure.
278 ctly communicate his or her wishes regarding donation, the family is often the only source of informa
279 ipid A2 receptor, the risk of living-related donation, the link between de novo MN and rejection, and
280 lue of antiPLA2R, the risk of living-related donation, the link between de novo MN and rejection, and
281 periods with lower rates of Zika-infectious donations, the cost-effectiveness of screening will be e
283 explore whether moral nudges promote charity donations to humanitarian organisations in a large (N =
286 ccessfully weaned from bypass (beating-heart donation versus donation after circulatory death; P = 0.
287 eople who have personally consented to organ donation via first person authorization (FPA) registrati
291 a dataset of more than $44 million in online donations, we find that 21% were made while opting to be
292 ge at donation and nondirected (vs directed) donation were associated with significantly decreased fi
295 ) completed a measure of beliefs about organ donation, were encouraged to discuss their fears and con
297 default is not to remove organs, and oppose donation where there is no evidence of preference but th
298 confirmed infertility or the need for semen donation who were eligible for standard bolus intra-uter
299 sent an ethical analysis of travel for organ donation with particular attention to lessons that can b
300 tions of the effect of physicians discussing donations with their patients; and opinions regarding gi